Amgen Inc. buy phonebroker
Start price
03.11.16
/
50%
€123.55
Target price
03.03.17
€162.36
Performance (%)
33.25%
End price
03.03.17
€162.70
Summary
This prediction ended on 03.03.17 with a price of €162.70. With a performance of 33.25% the BUY prediction by phonebroker was a big success. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | -3.663% | -3.663% | 10.577% | 26.401% |
| iShares Core DAX® | 0,23 % | -2,41 % | 15,34 % | 45,10 % |
| iShares Nasdaq 100 | 1,66 % | -1,66 % | 31,09 % | 76,36 % |
| iShares Nikkei 225® | -0,21 % | -2,50 % | 43,63 % | 49,59 % |
| iShares S&P 500 | 1,07 % | -1,58 % | 24,35 % | 57,07 % |
Comments by phonebroker for this prediction
In the thread Amgen Inc. diskutieren
phonebroker stimmt dem Sentiment von 'Buy' zu
phonebroker stimmt am 03.11.2016 dem Buy-Gesamtsentiment mit dem Kursziel 180 USD zu.